Analytical Data
-
Gene name
SCP2D1
- Application
-
Alternative Names
SCP2D1-AS1;C20orf78;Putative uncharacterized Protein SCP2D1-AS1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9UJQ7
-
Expression Region
1-156aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSMWKRSDH QPKIKAEDGP LVGQFEVLGS VPEPAMPHPL ELSEFESFPV FQDIRLHIRE VGAQLVKKVN AVFQLDITKN GKTILRWTID LKNGSGDMYP GPARLPADTV FTIPESVFME LVLGKMNPQK AFLAGKFKVS GKVLLSWKLE RVFKDWAKF
-
Molecular Weight
20 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SCP2D1, a protein encoded by the SCP2 gene, is part of the steroidogenic acute regulatory protein family and plays a critical role in lipid metabolism and cellular steroidogenesis. Recent studies have highlighted its significance in various physiological processes, including lipid transport and steroid hormone production, linking it to both metabolic disorders and endocrine dysfunctions. The exploration of SCP2D1 recombinant protein is essential for understanding its biological functions and potential impacts on health. Advances in recombinant DNA technology have enabled the production and purification of SCP2D1, facilitating detailed biochemical and structural analyses. By studying SCP2D1, researchers aim to elucidate its molecular mechanisms, interactions with other biomolecules, and contributions to key metabolic pathways. Furthermore, understanding the structure-function relationship of SCP2D1 could pave the way for therapeutic interventions in diseases related to lipid metabolism and hormone regulation, highlighting its potential as a target for drug design. The recombinant form of SCP2D1 can serve as a valuable tool for in vitro studies, allowing scientists to investigate its role in cellular processes and its potential as a biomarker for disease diagnosis or prognosis. Research on SCP2D1 is not only critical for basic science but also has significant implications in translational medicine, particularly concerning metabolic syndromes and hormonal imbalances. Thus, SCP2D1 represents a promising avenue for further research aimed at unlocking new treatment strategies and improving our understanding of metabolic health.
